Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

The Pharmacogenomics Journal 17, 419 (October 2017). doi:10.1038/tpj.2016.28

Authors: D Kringel, A Ultsch, M Zimmermann, J-P Jansen, W Ilias, R Freynhagen, N Griessinger, A Kopf, C Stein, A Doehring, E Resch & J Lötsch

from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2xAi10s
via IFTTT